{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:56:58Z","timestamp":1773975418496,"version":"3.50.1"},"reference-count":7,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:p>This Viewpoint examines questions about drug pricing, patient access, and fiscal sustainability of novel gene therapies for autosomal recessive deafness 9.<\/jats:p>","DOI":"10.1001\/jamaoto.2024.5189","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T16:34:44Z","timestamp":1741278884000},"page":"291","source":"Crossref","is-referenced-by-count":4,"title":["Gene Therapy for Hearing Loss\u2014Will the Price Be Right?"],"prefix":"10.1001","volume":"151","author":[{"given":"Lauren E.","family":"Miller","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2013Head & Neck Surgery, The Ohio State University College of Medicine, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver F.","family":"Adunka","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head & Neck Surgery, The Ohio State University College of Medicine, Columbus"},{"name":"Associate Editor, JAMA Otolaryngology\u2013Head & Neck Surgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay K.","family":"Rathi","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head & Neck Surgery, The Ohio State University College of Medicine, Columbus"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"10441","key":"ovp240014r1","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/S0140-6736(23)02874-X","article-title":"AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial.","volume":"403","author":"Lv","year":"2024","journal-title":"Lancet"},{"issue":"11","key":"ovp240014r5","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1377\/hlthaff.2023.00527","article-title":"Confronting high costs and clinical uncertainty: innovative payment models for gene therapies.","volume":"42","author":"Horrow","year":"2023","journal-title":"Health Aff (Millwood)"},{"issue":"23","key":"ovp240014r6","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1001\/jama.2024.6224","article-title":"Advancing access to cell and gene therapies in Medicaid.","volume":"331","author":"Kannarkat","year":"2024","journal-title":"JAMA"},{"issue":"6","key":"ovp240014r7","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1001\/jamapediatrics.2020.7140","article-title":"A budget impact analysis of gene therapy for sickle cell disease: the Medicaid perspective.","volume":"175","author":"DeMartino","year":"2021","journal-title":"JAMA Pediatr"},{"key":"ovp240014r2","unstructured":"Regeneron. Latest DB-OTO results show dramatically improved hearing to normal levels in a child with profound genetic deafness within 24 weeks. May 8, 2024. Accessed July 6, 2024. https:\/\/investor.regeneron.com\/news-releases\/news-release-details\/latest-db-oto-results-show-dramatically-improved-hearing-normal"},{"key":"ovp240014r3","unstructured":"Eli Lilly and Co. Positive phase 1\/2 clinical trial data for an investigational gene therapy for genetic hearing loss to be presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting. January 23, 2024. Accessed July 31, 2024. https:\/\/investor.lilly.com\/news-releases\/news-release-details\/positive-phase-12-clinical-trial-data-investigational-gene"},{"key":"ovp240014r4","unstructured":"Phares? S, Trusheim? M, Emond? S, Pearson? S. Managing the challenges of paying for gene therapy: strategies for market action and policy reform. Institute for Clinical and Economic Review. April 24, 2024. Accessed September 17, 2024. https:\/\/icer.org\/wp-content\/uploads\/2024\/04\/Managing-the-Challenges-of-Paying-for-Gene-Therapy-_-ICER-NEWDIGS-White-Paper-2024_final.pdf"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2830828\/jamaotolaryngology_miller_2025_vp_240014_1743795483.80341.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T15:00:52Z","timestamp":1744297252000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2830828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2024.5189","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,1]]}}}